Leflunomide in psoriatic arthritis: Results from a large European prospective observational study

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Arthritis care & research

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/acr.21848PMID 23042698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug Therapies for Peripheral Joint Disease in Psoriatic Arthritis: A Systematic Review

  2014cited by this paper
• A randomized placebo-controlled trial of methotrexate in psoriatic arthritis

  2012cited by this paper
• Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions.

  2008cited by this paper
• The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study

  2007influential reference
• Consensus on a core set of domains for psoriatic arthritis.

  2007cited by this paper
• Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis.

  2006cited by this paper
• Leflunomide Improves Psoriasis in Patients with Psoriatic Arthritis: An In-Depth Analysis of Data from the TOPAS Study

  2006cited by this paper
• Therapies for dactylitis in psoriatic arthritis. A systematic review.

  2006cited by this paper
• Therapies for peripheral joint disease in psoriatic arthritis. A systematic review.

  2006cited by this paper
• Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial

  2006cited by this paper
• Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.

  2006cited by this paper
• Prevalence of spondyloarthropathies in France: 2001

  2005cited by this paper
• Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway.

  2005cited by this paper
• Dactylitis in psoriatic arthritis: a marker for disease severity?

  2004cited by this paper
• Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.

  2004cited by this paper
• Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire.

  2002cited by this paper
• Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis.

  2001cited by this paper
• Comparison of disability and quality of life in rheumatoid and psoriatic arthritis.

  2001cited by this paper
• Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?

  1999cited by this paper
• Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study.

  1996cited by this paper
• Modeling Binary Data.

  1993cited by this paper
• Psoriatic arthritis in psoriatic patients.

  1984cited by this paper

• The frequency of psoriasis in Australian multiple sclerosis patients

  2025cites this paper
• Efficacy of Leflunomide Compared to Methotrexate in the Treatment of Moderate to Severe Plaques Psoriasis: A Randomized Controlled Clinical Trial

  2024cites this paper
• Pan American League of Associations for Rheumatology Recommendations for the Treatment of Psoriatic Arthritis

  2024cites this paper
• Treatment strategies for Spondyloarthritis: Implementation of precision medicine - Or "one size fits all" concept?

  2024cites this paper
• Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review.

  2023cites this paper
• Clinical practice guideline for the treatment of psoriatic arthritis in Colombia

  2023cites this paper
• Consensus statements for pharmacological management, monitoring of therapies, and comorbidity management of psoriatic arthritis in the United Arab Emirates

  2022cites this paper
• Leflunomide: Traditional immunosuppressant with concurrent antiviral effects

  2022cites this paper
• Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs for Psoriatic Arthritis: Findings and Implications From a Patient Centered Longitudinal Study in Brazil

  2022cites this paper
• Fatigue in psoriatic arthritis: Is it related to disease activity?

  2021cites this paper
• Recommendations of the Mexican College of Rheumatology for the management of psoriatic arthritis.

  2021cites this paper
• Recommendations of the Mexican College of Rheumatology for the management of psoriatic arthritis.

  2021cites this paper
• Traitement de fond et traitement ciblé du rhumatisme psoriasique

  2020cites this paper
• Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy? Analysis of data from a noninterventional study of rheumatoid arthritis patients initiating treatment with adalimumab

  2020cites this paper
• Manifestations of psoriatic arthritis in patients with psoriasis

  2020cites this paper
• Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology.

  2020cites this paper
• Medication persistence for psoriatic arthritis in a Brazilian real-world setting

  2019cites this paper
• The Etiology, Pathophysiology,Differential Diagnosis, Clinical Findings, and Treatment of Nail Psoriasis

  2019cites this paper
• Combination of leflunomide and benazepril reduces renal injury of diabetic nephropathy rats and inhibits high-glucose induced cell apoptosis through regulation of NF-κB, TGF-β and TRPC6

  2019cites this paper
• Efficacy and safety of leflunomide in psoriatic arthritis treatment: A single‐arm meta‐analysis

  2019cites this paper
• Modern pharmacotherapy of psoriatic arthritis

  2019cites this paper
• Safety of treatment options for spondyloarthritis: a narrative review

  2018cites this paper
• Treatment of Enthesitis, Dactylitis and Nail Lesions in Psoriatic Arthritis

  2018cites this paper
• Methotrexate and leflunomide survival in patients with psoriatic arthritis

  2018cites this paper
• Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set

  2018influential citation
• Dermatological Disorders

  2018cites this paper
• Effectiveness of conventional disease-modifying antirheumatic drugs in psoriatic arthritis: A systematic review.

  2018cites this paper
• Effectiveness of Conventional Disease-modifying Antirheumatic Drugs in Psoriatic Arthritis: A Systematic Review

  2018cites this paper
• [Psoriatic arthritis : Overview of drug therapy options and administration characteristics].

  2017cites this paper
• Treatment of psoriatic arthritis with traditional DMARD’s and novel therapies: approaches and recommendations

  2017cites this paper
• Nail psoriasis: clinical features, pathogenesis, differential diagnoses, and management

  2017cites this paper
• Treatment strategies for psoriatic arthritis.

  2017cites this paper
• Dermoscopy in terra firma‐forme dermatosis and dermatosis neglecta

  2017cites this paper
• Teriflunomide‐induced psoriasiform changes of fingernails: a new example of paradoxical side effect?

  2017cites this paper
• Nonbiologic Drugs in Pediatric Rheumatology

  2017cites this paper
• Psorijatični artritis i biološka terapija

  2017cites this paper
• Stratégies thérapeutiques dans le rhumatisme psoriasique

  2017cites this paper
• Eficacia de los fármacos antirreumáticos modificadores de la enfermedad sintéticos en artritis psoriásica: una revisión sistemática

  2017influential citation
• Arzneimitteltherapie der Psoriasis-Arthritis

  2017cites this paper
• Nail Psoriasis: A Review of Treatment Options

  2016cites this paper
• [Psoriatic arthritis : Overview of drug therapy options and administration characteristics].

  2016cites this paper
• Towards new measures of inflammation in spondyloarthritis

  2016cites this paper
• Oral Non-biologic Therapies and Non-pharmacological Therapies in PsA

  2016cites this paper
• An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets

  2016cites this paper
• A Case of Multicentric Carcinoid in a Patient with Psoriatic Spondyloarthropathy

  2015cites this paper
• Nail psoriasis.

  2015cites this paper
• Psoriatic Disease: Update on Traditional Disease-modifying Antirheumatic Drugs

  2015cites this paper
• On the interactions of leflunomide and teriflunomide within receptor cavity — NMR studies and energy calculations

  2015cites this paper
• 2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part II: Specific Management Recommendations

  2015cites this paper
• Making the next steps in psoriatic arthritis management: current status and future directions

  2015cites this paper
• Pharmacological therapy of spondyloarthritis

  2015cites this paper
• Psoriatic arthritis for the dermatologist.

  2015cites this paper
• Psoriatic arthritis: current therapy and future approaches.

  2015cites this paper
• Psoriatic arthritis: latest treatments and their place in therapy

  2015cites this paper
• Management of Psoriatic Arthritis: Traditional Disease-Modifying Rheumatic Agents and Targeted Small Molecules.

  2015cites this paper
• Targeting extra-articular manifestations in PsA: a closer look at enthesitis and dactylitis

  2015cites this paper
• Drug Therapies for Peripheral Joint Disease in Psoriatic Arthritis: A

  2014cites this paper
• Individualization of leflunomide dosing in rheumatoid arthritis patients.

  2014cites this paper
• Treatments for Nail Psoriasis: A Systematic Review by the GRAPPA Nail Psoriasis Work Group

  2014cites this paper
• The effectiveness of leflunomide in psoriatic arthritis.

  2014cites this paper
• Advances in the management of psoriatic

  2014cites this paper
• Treatment options for psoriatic arthritis

  2014cites this paper
• Proteomics focusing on immune markers in psoriatic arthritis.

  2014cites this paper
• The future of treatment for psoriatic arthritis

  2014cites this paper
• Advances in the management of psoriatic arthritis

  2014cites this paper
• Drug Therapies for Peripheral Joint Disease in Psoriatic Arthritis: A Systematic Review

  2014cites this paper
• Treatment (biotherapy excluded) of psoriatic arthritis: an appraisal of methodological quality of international guidelines

  2014cites this paper
• Can traditional disease-modifying anti-rheumatic drugs be withdrawn or tapered in psoriatic arthritis?

  2013cites this paper
• Safety evaluation of leflunomide in rheumatoid arthritis

  2013cites this paper
• Enthesitis in psoriatic arthritis.

  2013cites this paper
• [Psoriatic arthritis and general recommendations for targeted therapy of spondyloarthritis].

  2013cites this paper
• Immunology of atopic dermatitis: novel insights into mechanisms and immunomodulatory therapies.

  2013cites this paper
• Psoriatic arthritis: current therapy and future directions

  2013cites this paper
• Эффективность и переносимость лефлуномида (Арава ® ) в терапии псориатического артрита

  2013cites this paper
• Therapie der Psoriasisarthritis

  2013cites this paper
• Targets and Therapy

  year unknowncites this paper
• Artritis psoriásica

  year unknowncites this paper